• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Regulation of immuno-check point by hyperthermia

Research Project

Project/Area Number 16K01482
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Rehabilitation science/Welfare engineering
Research InstitutionKyoto University of Advanced Science

Principal Investigator

KOKURA SATOSHI  京都先端科学大学, 健康医療学部, 教授 (80347442)

Project Period (FY) 2016-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2018: ¥260,000 (Direct Cost: ¥200,000、Indirect Cost: ¥60,000)
Fiscal Year 2017: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywordsハイパーサーミア / 温熱処理 / 免疫チェックポイント / PD-L1 / IFNγ / 温熱療法 / PD-1 / RT-PCR / FACS / 癌細胞 / 脂肪細胞由来幹細胞 / IL-6 / IFN-gannma / 癌免疫逃避機構 / 免疫療法
Outline of Final Research Achievements

After stimulating by IFNgamma in two or more cancer cell stocks and accelerating the onet of PD-L1, I considered the impact of hyperthermia. As a result, with a cancer cell stock, the cell strain which an onet reinforces greatly also has a dispersion, and an observe thing did not come to conclude the tropesis of the onet suppression as a whole. Then, I considered the impact of a thermal treatment on an onet of PD-L1 without the pre-stimulus of IFNgamma. As a result, the onet of PD-L1 was reinforcing on some cancer cell stocks. About the mechanism, by our investigation, it became clear that a yield of IFNgamma from a cancer cell rises by thermal treatment, and I guessed that I was reinforcing the onet of PD-L1 in autocrine.

Academic Significance and Societal Importance of the Research Achievements

現在注目されている免疫チェックポイントの阻害方法は、それぞれのリガンド(キラーTリンパ球上のPD-1、癌細胞上のPD-L1)を抗体でブロックする方法である。本研究では、抗体ではなく、腫瘍を加温することで腫瘍組織内の癌細胞上のPD-L1の発現の変動を検討することにより、免疫チェックポイント阻害剤の適応や使用容量を適切にすることが可能である。場合によっては、高額な免疫チェックポイント阻害剤(抗体)の使用量を減じることも可能で、医療経済へ及ぼす影響も見逃すことはできない。

Report

(5 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (26 results)

All 2019 2018 2017 2016

All Journal Article (4 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 4 results,  Open Access: 4 results) Presentation (21 results) (of which Int'l Joint Research: 2 results,  Invited: 15 results) Book (1 results)

  • [Journal Article] Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study.2018

    • Author(s)
      Nishida S, Ishikawa T, Egawa S, Koido S, Yanagimoto H, Ishii J, Kanno Y, Kokura S, Yasuda H, Oba MS, Sato M, Morimoto S, Fujiki F,Eguchi H, Nagano H, Kumanogoh A, Unno M, KonM, Shimada H, Ito K,Homma S, Oka Y, Morita S, Sugiyama H.
    • Journal Title

      Cancer Immunol Res.

      Volume: 6(3) Pages: 1-12

    • Related Report
      2018 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.2018

    • Author(s)
      Ishikawa T, Okayama T, Sakamoto N, Ideno M, Oka K, Enoki T, Mineno J, Yoshida N, Katada K, Kamada K, Uchiyama K, Handa O, Takagi T, Konishi H, Kokura S, Uno K, Naito Y, Itoh Y.
    • Journal Title

      Int J Cancer

      Volume: 142 Issue: 12 Pages: 2599-2609

    • DOI

      10.1002/ijc.31285

    • Related Report
      2018 Research-status Report 2017 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] The amino acid-rich elemental diet Elental; preserves lean body mass during chemo- or chemoradiotherapy for esophageal cancer.2017

    • Author(s)
      Ishikawa T, Yasuda T, Doi T, Okayama T, Sakamoto N, Gen Y, Dohi O, Yoshida N, Kamada K, Uchiyama K, Handa O, Takagi T, Konishi H, Yagi N, Kokura S, Naito Y, Itoh Y.
    • Journal Title

      Oncol Rep

      Volume: 36 Pages: 1093-100

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] The Present State of the Hyperthermia in Japan, and by What Kind of Way Should We Progress from Now on?.2016

    • Author(s)
      Satoshi Kokura.
    • Journal Title

      Bulletin of the Faculty of Health and Medical Sciences, Kyoto Gakuen University

      Volume: 1 Pages: 13-19

    • NAID

      120006332962

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] ハイパーサーミアと遺伝子改変Tリンパ球療法との併用2019

    • Author(s)
      古倉 聡
    • Organizer
      第33回東海ハイパーサーミア研究会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] 温熱療法と免疫療法は、最善の組み合わせか?2019

    • Author(s)
      古倉 聡
    • Organizer
      日本ハイパーサーミア学会第36回大会
    • Related Report
      2019 Annual Research Report
  • [Presentation] たけだ診療所における、樹状細胞WT-1ペプチドワクチン療法の現状2019

    • Author(s)
      古倉 聡
    • Organizer
      WT1樹状細胞研究会
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] 温熱は、新規癌免疫療法の効果を増強する2019

    • Author(s)
      古倉 聡
    • Organizer
      第22回癌治療増感研究シンポジウム
    • Related Report
      2019 Annual Research Report
    • Invited
  • [Presentation] Healthcare innovation and technology for Anti-Aging2018

    • Author(s)
      Satoshi Kokura
    • Organizer
      Green ASIA and Sustainability Forum
    • Related Report
      2018 Research-status Report
    • Int'l Joint Research / Invited
  • [Presentation] ハイパーサーミアと放射線治療法・化学療法・免疫療法との併用のメカニズムと治療効果.2018

    • Author(s)
      古倉 聡
    • Organizer
      ハイパーサーミアについて理解を深める講演会
    • Related Report
      2018 Research-status Report
    • Invited
  • [Presentation] 進行癌を慢性疾患に2018

    • Author(s)
      古倉 聡
    • Organizer
      よみうり市民公開講座
    • Related Report
      2018 Research-status Report
    • Invited
  • [Presentation] 癌と向き合う治療のあり方2018

    • Author(s)
      古倉 聡
    • Organizer
      ハイパーサーミア市民講座in 鶴岡
    • Related Report
      2018 Research-status Report
    • Invited
  • [Presentation] がんの集学的治療の一つとしての免疫療法を考える2018

    • Author(s)
      古倉 聡
    • Organizer
      よみうり市民公開講座
    • Related Report
      2018 Research-status Report
    • Invited
  • [Presentation] 集学的治療の一つとしてのハイパーサーミア.2018

    • Author(s)
      古倉 聡
    • Organizer
      ハイパーサーミア市民公開講座 in山形
    • Related Report
      2018 Research-status Report
    • Invited
  • [Presentation] 「私とハイパーサーミアとの30年」2017

    • Author(s)
      古倉 聡
    • Organizer
      九州中国四国ハイパーサーミア研究会
    • Related Report
      2017 Research-status Report
    • Invited
  • [Presentation] ハイパーサーミア と 放射線療法・化学療法・免疫療法 との併用のメカニズムと治療効果2017

    • Author(s)
      古倉 聡、
    • Organizer
      庄内クリエート勉強会
    • Related Report
      2017 Research-status Report
    • Invited
  • [Presentation] ハイパーサーミアと放射線療法・化学療法・免疫療法との併用効果のメカニズムと治療の実際2017

    • Author(s)
      古倉 聡、
    • Organizer
      東海ハイパーサミア研究会
    • Related Report
      2017 Research-status Report
    • Invited
  • [Presentation] 「私とハイパーサーミアとの30年間のお付き合い」2017

    • Author(s)
      古倉 聡、
    • Organizer
      第19回関西ハイパーサーミア研究会
    • Related Report
      2017 Research-status Report
    • Invited
  • [Presentation] 日本ハイパーサーミア学会 学会賞受賞講演2017

    • Author(s)
      古倉 聡
    • Organizer
      日本ハイパーサーミア学会第34回大会
    • Related Report
      2017 Research-status Report
    • Invited
  • [Presentation] Hyperthermia, the Adjunct Modality to Enhance Effects of Standard Treatment and New Trends of Treatment Modality2016

    • Author(s)
      古倉 聡
    • Organizer
      天壇普華RF8温熱治療機器発表会.
    • Place of Presentation
      北京
    • Year and Date
      2016-11-20
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research / Invited
  • [Presentation] ハイパーサーミアの癌細胞上のPD-L1の発現に対する影響2016

    • Author(s)
      古倉 聡、松山竜三、柏木隆宏
    • Organizer
      第13回がんワクチン療法研究会学術集会.
    • Place of Presentation
      因島
    • Year and Date
      2016-11-05
    • Related Report
      2016 Research-status Report
  • [Presentation] 進行膵癌に対するゲムシタビン併用WT1ペプチドワクチン療法ランダム化第II相臨床試験.2016

    • Author(s)
      小井戸薫雄、西田純幸、石川 剛、江川新一、石井 淳、菅野良秀、柳本泰明、古倉 聡、森本創世子、大庭真梨、江口英利、島田英昭、本間 定、森田智視、杉山治夫.
    • Organizer
      第54回日本癌治療会ミニシンポジウム
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-20
    • Related Report
      2016 Research-status Report
  • [Presentation] 進行膵癌に対するゲムシタビン併用WT1ペプチドワクチン療法のランダム化第2相試験.2016

    • Author(s)
      石川 剛、西田純幸、江川新一、小井戸薫雄、石井 淳、菅野良秀、柳本泰明、古倉 聡、森本創世子、大庭真梨、岡 芳弘、杉山 治夫
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      横浜
    • Year and Date
      2016-10-06
    • Related Report
      2016 Research-status Report
  • [Presentation] 癌免疫細胞療法にハイパーサーミアを併用する意義.2016

    • Author(s)
      古倉 聡、松山竜三、柏木隆宏.
    • Organizer
      日本ハイパーサーミア学会第33回大会.
    • Place of Presentation
      筑波
    • Year and Date
      2016-09-02
    • Related Report
      2016 Research-status Report
  • [Presentation] 癌免疫療法にハイパーサーミアを併用する意義.2016

    • Author(s)
      古倉 聡、松山竜三、舟木 準、水野麻利、柏木隆宏、出野美津子.
    • Organizer
      第45回放射線による制癌シンポジウム.
    • Place of Presentation
      大阪
    • Year and Date
      2016-07-15
    • Related Report
      2016 Research-status Report
  • [Book] Hyperthermic Oncology from Bench to Bedside2016

    • Author(s)
      Kokura S, Yoshikawa T, Ohnishi T,
    • Total Pages
      444
    • Publisher
      Springer
    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi